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Preface   
	  
	  
According to the American Cancer Society, Non- Hodgkin Lymphoma (NHL) is one of 
the most common cancers in the United States, making up about 4% of all cancers.  85% of these 
originate in B lymphocytes.  A number of these tumors are caused by genome rearrangements 
that happen as a result of incorrect repair to mistakes made in the DNA known as genome 
instability.  My thesis attempts to understand roles for proteins involved in stabilizing the 
genome, and to elucidate their importance in the prevention of diseases such as Non- Hodgkin 
Lymphoma.   It is my hope that this research can one day contribute to the discovery of cancer 
therapeutics aimed at targeting the DNA damage response in malignant cells.  
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Abstract 
 
Many B cell lymphomas are driven by translocations between a proto-oncogene and the 
B cell specific immunoglobulin heavy chain (IgH) gene. These translocations are thought to be 
the result of aberrant class switch recombination (CSR), a developmental process in B cells that 
requires programmed DNA double strand breaks (DSBs). The Mre11/Rad50/Nbs1 (MRN) 
complex plays multiple roles in DNA repair including sensing and binding DSBs, tethering and 
processing broken ends, and signaling to downstream repair pathways. To explore role for MRN 
in the translocation process, we engineered mice that harbor Mre11 deficiencies in B 
lymphocytes.  These mice exhibit an 80% defect in CSR, with a significant accumulation of 
unrepaired DNA breaks in IgH. These unrepaired breaks are capable of participating in 
translocations but, surprisingly, mice do not succumb to B cell lymphoma. Thus, it is possible 
that MRN has crucial roles in tumor formation. 
Following translocation, the proto-oncogene must become deregulated in order to confer 
growth advantage to a cell. Regulatory elements within IgH are known to be required for this 
deregulation; however the regulatory role of distal cis-acting elements in deregulation has not 
been examined.  To determine if there are elements outside of IgH that are responsible for this, 
we utilize a transgenic mouse model in which a transgene containing the entire IgH locus is 
inserted into different chromosomal locations in different mouse lines. We observe that the 
transgene is able to undergo oncogenic translocations at multiple chromosomal sites and in 
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multiple orientations with respect to the endogenous locus. Sequencing reveals that these 
translocations are similar to translocations to endogenous IgH. 
These results suggest that Mre11 plays multiple roles in DNA repair during B 
lymphocyte development, which has implications for the formation of lymphomagenic 
translocations.  Additionally, the larger chromosomal environment, outside of the 230kb IgH 
locus, plays only a minor role in translocation and subsequent deregulation of an oncogene. 
  
